These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25091703)

  • 1. Interleukin-1β promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the Ca²⁺-dependent activation of ERK.
    Chung YH; Choi B; Song DH; Song Y; Kang SW; Yoon SY; Kim SW; Lee HK; Chang EJ
    Int J Biochem Cell Biol; 2014 Sep; 54():198-207. PubMed ID: 25091703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1 mediates RANKL-induced osteoclast formation and activity.
    Wang Y; Dong G; Jeon HH; Elazizi M; La LB; Hameedaldeen A; Xiao E; Tian C; Alsadun S; Choi Y; Graves DT
    J Immunol; 2015 Mar; 194(6):2878-87. PubMed ID: 25694609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U; Patel K; Rosol TJ; Ostrowski MC
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-associated protein light chain 3 regulates Cdc42-dependent actin ring formation in osteoclast.
    Chung YH; Yoon SY; Choi B; Sohn DH; Yoon KH; Kim WJ; Kim DH; Chang EJ
    Int J Biochem Cell Biol; 2012 Jun; 44(6):989-97. PubMed ID: 22465708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
    Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
    Cao Y; Jansen ID; Sprangers S; Stap J; Leenen PJ; Everts V; de Vries TJ
    J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway.
    Liu S; Zhu L; Zhang J; Yu J; Cheng X; Peng B
    Biochem Pharmacol; 2016 Apr; 106():82-93. PubMed ID: 26947453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
    Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
    Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL).
    Ang ES; Zhang P; Steer JH; Tan JW; Yip K; Zheng MH; Joyce DA; Xu J
    J Cell Physiol; 2007 Sep; 212(3):787-95. PubMed ID: 17477372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1.
    Ye S; Fowler TW; Pavlos NJ; Ng PY; Liang K; Feng Y; Zheng M; Kurten R; Manolagas SC; Zhao H
    PLoS One; 2011; 6(11):e27285. PubMed ID: 22073305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.
    Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Tatamiya M; Nakao N; Yoshida N; Nakayama K
    Immunol Lett; 2003 Sep; 88(3):193-8. PubMed ID: 12941478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
    Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
    Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase.
    Choe JY; Park KY; Kim SK
    Mediators Inflamm; 2015; 2015():597512. PubMed ID: 26347587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
    Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
    Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.